Empirico Inc.
Shannon Bruse is a seasoned professional in the field of biology and therapeutics with extensive experience in both academia and industry. Currently serving as Cofounder, SVP, and Head of Target Discovery and Biology at Empirico Inc. since January 2018, Bruse plays a pivotal role in leveraging biological datasets and programmable biology for therapeutic developments. Previous roles include Associate Director of Translational Genetics at Regeneron Pharmaceuticals and various positions at Mirus Bio LLC, including Senior Scientist and Director of Scientific Operations. Bruse's career commenced with research roles at Case Western Reserve University and Rutgers University, building a strong foundation in scientific inquiry and innovation.
This person is not in any teams
Empirico Inc.
1 followers
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.The company's platform uses biological datasets, human genetics, and programmable biology to power target discovery and development, enabling scientists to systematically generate, interrogate, and prioritizehigh-confidence therapeutic hypotheses.